Abdulkader Puranwala
Stock Analyst at ICICI Securities
(3.39)
# 2,386
Out of 4,698 analysts
40
Total ratings
61.5%
Success rate
10.5%
Average return
Main Sectors:
Stocks Rated by Abdulkader Puranwala
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSE: ALKEM Alkem Laboratories Limited | Maintained: Buy | ₹6,065 → ₹6,850 | ₹5,143 | +33.20% | 4 | May 28, 2026 | |
| NSE: APOLLOHOSP Apollo Hospitals Enterprise Limited | Maintained: Buy | ₹8,840 → ₹8,820 | ₹8,711 | +1.26% | 3 | Feb 12, 2026 | |
| NSE: GLENMARK Glenmark Pharmaceuticals Limited | Maintained: Sell | ₹1,570 → ₹1,640 | ₹2,440 | -32.78% | 3 | Feb 3, 2026 | |
| NSE: GLAND Gland Pharma Limited | Maintained: Buy | ₹2,115 → ₹2,275 | ₹2,886 | -21.16% | 2 | Jan 29, 2026 | |
| NSE: AKUMS Akums Drugs and Pharmaceuticals Limited | Maintained: Buy | ₹655.00 → ₹600.00 | ₹762.55 | -21.32% | 3 | Dec 22, 2025 | |
| NSE: SUNPHARMA Sun Pharmaceutical Industries Limited | Maintained: Buy | ₹1,800 → ₹1,965 | ₹1,909 | +2.91% | 2 | Nov 6, 2025 | |
| NSE: NATCOPHARM NATCO Pharma Limited | Maintained: Sell | ₹890.00 → ₹810.00 | ₹833.00 | n/a | 2 | Aug 14, 2025 | |
| NSE: METROPOLIS Metropolis Healthcare Limited | Maintained: Buy | ₹600.00 | ₹588.65 | n/a | 1 | Aug 11, 2025 | |
| NSE: FORTIS Fortis Healthcare Limited | Upgraded: Hold | ₹855.00 | ₹909.90 | n/a | 1 | Aug 8, 2025 | |
| NSE: KIMS Krishna Institute of Medical Sciences Limited | Downgraded: Sell | ₹630.00 | ₹772.50 | n/a | 2 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | ₹5,400 | ₹9,196 | n/a | 1 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹2,110 → ₹1,950 | ₹2,126 | n/a | 2 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹900.00 | ₹805.25 | n/a | 1 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ₹1,445 → ₹1,300 | ₹1,652 | n/a | 2 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹590.00 | ₹705.00 | n/a | 1 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹2,900 → ₹1,500 | ₹1,872 | n/a | 2 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | ₹1,000 | ₹1,504 | n/a | 2 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹910.00 → ₹486.62 | ₹579.80 | n/a | 2 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹1,200 | ₹1,161 | n/a | 1 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | ₹1,400 | ₹463.40 | n/a | 1 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ₹2,250 | ₹2,938 | n/a | 1 | Feb 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹1,000 | ₹1,140 | n/a | 1 | Feb 6, 2025 |
Alkem Laboratories Limited
May 28, 2026
Maintained: Buy
Price Target: ₹6,065 → ₹6,850
Current: ₹5,143
Upside: +33.20%
Apollo Hospitals Enterprise Limited
Feb 12, 2026
Maintained: Buy
Price Target: ₹8,840 → ₹8,820
Current: ₹8,711
Upside: +1.26%
Glenmark Pharmaceuticals Limited
Feb 3, 2026
Maintained: Sell
Price Target: ₹1,570 → ₹1,640
Current: ₹2,440
Upside: -32.78%
Gland Pharma Limited
Jan 29, 2026
Maintained: Buy
Price Target: ₹2,115 → ₹2,275
Current: ₹2,886
Upside: -21.16%
Akums Drugs and Pharmaceuticals Limited
Dec 22, 2025
Maintained: Buy
Price Target: ₹655.00 → ₹600.00
Current: ₹762.55
Upside: -21.32%
Sun Pharmaceutical Industries Limited
Nov 6, 2025
Maintained: Buy
Price Target: ₹1,800 → ₹1,965
Current: ₹1,909
Upside: +2.91%
NATCO Pharma Limited
Aug 14, 2025
Maintained: Sell
Price Target: ₹890.00 → ₹810.00
Current: ₹833.00
Upside: n/a
Metropolis Healthcare Limited
Aug 11, 2025
Maintained: Buy
Price Target: ₹600.00
Current: ₹588.65
Upside: n/a
Fortis Healthcare Limited
Aug 8, 2025
Upgraded: Hold
Price Target: ₹855.00
Current: ₹909.90
Upside: n/a
Krishna Institute of Medical Sciences Limited
Aug 8, 2025
Downgraded: Sell
Price Target: ₹630.00
Current: ₹772.50
Upside: n/a
Aug 7, 2025
Maintained: Sell
Price Target: ₹5,400
Current: ₹9,196
Upside: n/a
Aug 7, 2025
Maintained: Hold
Price Target: ₹2,110 → ₹1,950
Current: ₹2,126
Upside: n/a
Aug 6, 2025
Maintained: Hold
Price Target: ₹900.00
Current: ₹805.25
Upside: n/a
Aug 6, 2025
Upgraded: Buy
Price Target: ₹1,445 → ₹1,300
Current: ₹1,652
Upside: n/a
Aug 5, 2025
Maintained: Hold
Price Target: ₹590.00
Current: ₹705.00
Upside: n/a
Aug 1, 2025
Maintained: Hold
Price Target: ₹2,900 → ₹1,500
Current: ₹1,872
Upside: n/a
Jul 29, 2025
Maintained: Sell
Price Target: ₹1,000
Current: ₹1,504
Upside: n/a
Jul 25, 2025
Maintained: Buy
Price Target: ₹910.00 → ₹486.62
Current: ₹579.80
Upside: n/a
Jul 24, 2025
Maintained: Hold
Price Target: ₹1,200
Current: ₹1,161
Upside: n/a
Mar 25, 2025
Initiated Coverage: Buy
Price Target: ₹1,400
Current: ₹463.40
Upside: n/a
Feb 17, 2025
Upgraded: Buy
Price Target: ₹2,250
Current: ₹2,938
Upside: n/a
Feb 6, 2025
Maintained: Hold
Price Target: ₹1,000
Current: ₹1,140
Upside: n/a